Biosensor Platform Leverages Silicon Semiconductor Manufacturing for Scale
Technology Designed to Provide a Better View of Metabolic Health by Combining Glucose Information with Context Around Activities of Daily Living in One Device
$58 Million in Funding…
We evaluated the effectiveness of a mobile health (mHealth) intervention for diabetic kidney disease patients by conducting a 12-month randomized controlled trial among 126 type 2 diabetes mellitus patients with moderately increased albuminuria (urinary…
Continue Reading
What You Should Know:
– MD Revolution, known for its remote care management solutions, collaborates with Dexcom to integrate cutting-edge continuous glucose monitoring systems into its platform.
– Dexcom, a global leader in real-time continuous glucose monitoring, serves…
Continue Reading
Labour has announced a new partnership with Virgin Media O2, to ensure every child with type 1 diabetes can benefit from the latest technology. Labour also said it will digitise the red book given to…
Continue Reading
This week, San Diego-based company Biolinq raked in $58 million in a funding round led by Alpha Wave Ventures, bringing its total funding to date to $178 million.
The company, founded in 2012, is developing…
Continue Reading
What You Should Know: – Biolinq, a provider of precision wearable biosensors for metabolic health secures $58M led by Alpha Wave Ventures. The round will include participation from Niterra’s corporate venture capital fund jointly…
Continue Reading
California-based Biolinq, a health technology company developing precision multi-analyte wearable biosensors for metabolic health, announced it scored $58 million in financing.Alpha Wave Ventures led the round, with participation from Niterra’s corporate venture capital fund,…
Continue Reading
An Overview of the Wearable Market in Healthcare
MarketsandMarkets suggests that the global market for wearable healthcare devices will approach $70 billion by 2028, with annual growth in the market exceeding 11 percent per year….
Remote patient monitoring is not new, but technological advances in devices and data transfer have enabled many new uses and opportunities. Today, RPM and Internet of Medical Things (IoMT) devices can be used to…
Continue Reading
Roche has developed a continuous glucose monitor with predictive algorithms that gives patients with diabetes a way of managing their condition and reducing uncertainty, with a potentially powerful impact on their quality of life. Roche…
Continue Reading
